Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imipramine-flupenthixol decanoate interaction.

P E Cook, S W Dermer, J Cardamone

    Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
    |April 1, 1986
    PubMed
    Summary

    Co-administering flupenthixol decanoate with imipramine led to dangerously high imipramine and desipramine levels in a schizophrenia patient. This case highlights risks and suggests guidelines for combining antipsychotics and antidepressants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sources of microorganisms in pozol, a traditional Mexican fermented maize dough.

    World journal of microbiology & biotechnology·2014
    Same author

    Bacillus fermentation of soybeans.

    World journal of microbiology & biotechnology·2014
    Same author

    Transcriptional profiling of Anopheles gambiae mosquitoes for adult age estimation.

    Insect molecular biology·2010
    Same author

    Care of the recovering schizophrenic: what can the family doctor do?

    Canadian family physician Medecin de famille canadien·2010
    Same author

    Trends in technology, trade and consumption likely to impact on microbial food safety.

    International journal of food microbiology·2010
    Same author

    Survey of local authority approaches to investigating sporadic cases of suspected food poisoning.

    Communicable disease and public health·2000

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology
    • Neuroscience

    Background:

    • Schizophrenia treatment often involves multiple psychotropic medications.
    • Combining antipsychotics and antidepressants can be complex due to potential drug-drug interactions.
    • Imipramine is a tricyclic antidepressant, and flupenthixol decanoate is a long-acting injectable antipsychotic.

    Observation:

    • A case study involving a patient with schizophrenia receiving concurrent flupenthixol decanoate and imipramine.
    • The patient exhibited unexpectedly high plasma concentrations of imipramine and its active metabolite, desipramine.
    • This suggests a significant pharmacokinetic interaction between the two drugs.

    Findings:

    • Co-administration of flupenthixol decanoate and imipramine resulted in supra-therapeutic levels of imipramine and desipramine.
    • A review of existing literature on neuroleptic-antidepressant combinations was conducted.
    • Potential mechanisms for the observed interaction include inhibition of cytochrome P450 enzymes by flupenthixol.

    Implications:

    • Clinicians should exercise caution when prescribing flupenthixol decanoate and imipramine concurrently.
    • Monitoring of imipramine and desipramine plasma levels is recommended in such cases.
    • Development of evidence-based guidelines is crucial to minimize iatrogenic effects from combined psychotropic therapy.

    Related Experiment Videos